These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28833582)

  • 1. A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs.
    Sato M; Veir JK; Legare M; Lappin MR
    J Vet Intern Med; 2017 Sep; 31(5):1502-1507. PubMed ID: 28833582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy.
    Gregory CR; Stewart A; Sturges B; DeManvelle T; Cannon A; Ortega T; Harb M; Morris RE
    Transplant Proc; 1998 Dec; 30(8):4143-8. PubMed ID: 9865328
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds.
    Fukushima K; Eguchi N; Ohno K; Kanemoto H; Takahashi M; Igarashi H; Ohmi A; Nakashima K; Tsujimoto H
    J Vet Med Sci; 2016 Feb; 78(2):265-9. PubMed ID: 26460312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008).
    Colopy SA; Baker TA; Muir P
    J Am Vet Med Assoc; 2010 Feb; 236(3):312-8. PubMed ID: 20113244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory drugs and their application to the management of canine immune-mediated disease.
    Whitley NT; Day MJ
    J Small Anim Pract; 2011 Feb; 52(2):70-85. PubMed ID: 21265846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of leflunomide as an adjunctive therapy in dogs with non-associative immune-mediated thrombocytopenia: 20 cases (2008-2021).
    Spear DJ; Crouse ZJ; Kearns SA
    J Small Anim Pract; 2024 Apr; 65(4):261-269. PubMed ID: 38433454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of cyclosporine and leflunomide in treating inflammatory colorectal polyps in miniature dachshunds.
    Tani A; Seno T; Yokoyama N; Nakagawa T; Tomiyasu H; Goto-Koshino Y; Tsujimoto H; Ohno K
    J Vet Med Sci; 2020 Apr; 82(4):437-440. PubMed ID: 32062634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of presumptive primary immune-mediated thrombocytopenia with mycophenolate mofetil versus cyclosporine in dogs.
    Cummings FO; Rizzo SA
    J Small Anim Pract; 2017 Feb; 58(2):96-102. PubMed ID: 28160307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of leflunomide in the canine renal transplantation model.
    McChesney LP; Xiao F; Sankary HN; Foster PF; Sharma S; Haklin M; Williams JW
    Transplantation; 1994 Jun; 57(12):1717-22. PubMed ID: 8016874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide with prednisone or nonsteroidal anti-inflammatory drug therapy is safe and tolerated for long-term treatment of immune-mediated polyarthritis in 27 dogs.
    Chesne RB; Doornink MT; Sri-Jayantha LSH; Urie BK
    J Am Vet Med Assoc; 2024 Sep; 262(9):1188-1192. PubMed ID: 38608652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive therapy in dogs and cats. Properties of drugs and their use in various immune-mediated diseases].
    Rieder J; Mischke R
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Apr; 46(2):105-118. PubMed ID: 29727898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
    Wang A; Smith JR; Creevy KE
    J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide: new indication. In psoriatic rheumatism: too many risks, too little efficacy.
    Prescrire Int; 2005 Aug; 14(78):123-6. PubMed ID: 16106593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.
    Maddison P; Kiely P; Kirkham B; Lawson T; Moots R; Proudfoot D; Reece R; Scott D; Sword R; Taggart A; Thwaites C; Williams E
    Rheumatology (Oxford); 2005 Mar; 44(3):280-6. PubMed ID: 15657072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of adverse effects of mycophenolate mofetil administration to dogs with immune-mediated disease.
    Fukushima K; Lappin M; Legare M; Veir J
    J Vet Intern Med; 2021 Sep; 35(5):2215-2221. PubMed ID: 34231261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.
    Kaltwasser JP; Nash P; Gladman D; Rosen CF; Behrens F; Jones P; Wollenhaupt J; Falk FG; Mease P;
    Arthritis Rheum; 2004 Jun; 50(6):1939-50. PubMed ID: 15188371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity.
    de Souza RC; de Souza FHC; Miossi R; Shinjo SK
    Clin Exp Rheumatol; 2017; 35(6):1011-1013. PubMed ID: 28422003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leflunomide--a new drug for pharmacological immunomodulation].
    Wozel G; Pfeiffer C
    Hautarzt; 2002 May; 53(5):309-15. PubMed ID: 12063741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide use in renal transplantation.
    Leca N
    Curr Opin Organ Transplant; 2009 Aug; 14(4):370-4. PubMed ID: 19512928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.